ThyCa To Award New Research Grants in 2022, in Cooperation with ATA and AAES02/2022
Grant Applications Open to Researchers Worldwide
ThyCa: Thyroid Cancer Survivors’ Association Inc., is pleased to announce that it will award new grants for thyroid cancer research in 2022.
New grant recipients will be selected by an independent expert panel of the American Thyroid Association (ATA), and one grant recipient will be selected by an independent expert panel of the American Association of Endocrine Surgeons (AAES). One of the ATA selected grants will be in partnership with Bite Me Cancer. The panels will rank the proposals according to their scientific merit and select the top proposals. ThyCa will also award several continuation grants.
Each ThyCa ATA grant will be for 2 years. The deadline for applications for the ThyCa ATA grants is February 22, 2022. For details and application information, visit https://atagrantsandawards.smapply.org/.
The ThyCa AAES grant will be a 1-year grant. The deadline for applications for the ThyCa AAES grant is February 15, 2022. For details and application information, visit https://www.aaesfoundation.org/awards/application.
The ThyCa ATA grants will support: (1) research on follicular-cell-derived thyroid cancer, including papillary, follicular, anaplastic, and variants, and (2) research on medullary thyroid cancer. One grant will be named the Ric Blake Memorial Thyroid Cancer Research Grant, in memory and honor of ThyCa co-founder Ric Blake.
ThyCa is committed to supporting research with the goal of cures for all thyroid cancer. ThyCa began funding research grants in 2003. They are the first grants to be funded entirely by thyroid cancer patients, caregivers, and friends. ThyCa has awarded more than $2.6 million for thyroid cancer research, to researchers in Argentina, France, Germany, Poland, Sweden, Switzerland, United Kingdom, and United States.
ThyCa thanks all our donors for making possible our research funding program.